Clinical trial

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

NCT05817110

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-04-20

PhaseN/A

Study timeline

Study start (actual)2023-04-20Date precision: day

Registry last updated2026-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Malignancyunresolved

Interventions

Participant CohortOTHER

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

Mexico CityMexico1 CairoEgypt1 MonterreyNuevo León, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05817110 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.